Health Condition 1: G809- Cerebral palsy, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Children physically and mentally handicapped due to cerebral palsy. 2.Children with delayed growth and milestone development. 3.Already diagnosed cases of CP
Exclusion criteria
Exclusion criteria: 1.Children below 1years and above 10 years of age. 2.Children of CP with major congenital disorder & other disease status viz. Juvenile DM, Acute infections etc. 3.Children with any progressive neurologic anomalies. 4.Child suffering from any Muscular dystrophy. 5.Children with severe systemic illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The research drug is expected to be beneficial for improving symptoms of cerebral palsy like muscle spasm, increase tendon extensibility, pain relief, inflammation, swelling and other symptoms of aggravated Vata Dosha, reduction in muscle spasticity and facilitate free movement of joint preventing from deformities and contractures.Timepoint: Three months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Matra Basti shows good result in CP patients, especially by improving growth (height, weight, chest circumference) and development (head holding and sitting) 2.Ksheerabala oil is rejuvenating, which helps to repair the damaged tissue. It also provides nourishment to the nerves, brain, and spinal structures. The main ingredient of Ksheerabala Oil is Bala (Sida Cordifolia), which is a potent neuroprotective herbTimepoint: three months | — |
Countries
India
Contacts
State Ayurvedic Collage and Hospital, Turiyaganja, Lucknow